Clinical Trial Update: Different Doses of Tyrosine Adsorbed Tree Pollen Allergoid With Monophosphoryl Lipid A (MPL) in Patients Sensitized to Tree Pollen [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating different doses of Tyrosine Adsorbed Tree Pollen Allergoid with MPL in patients with Type I Hypersensitivity due to tree pollen were co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Hypersensitivity

Drugs mentioned

• Tyrosine Adsorbed Tree Pollen Allergoid with MPL (not specified)

Snippet

Sponsor: Allergy Therapeutics | Conditions: Type I Hypersensitivity | Phase 2 | Status: COMPLETED